The Office of the Controller General of Patents, Designs, and Trade Marks (CGPDTM) released the Draft CRI Guidelines, 2025 on March 25, 2025. The Draft aims to provide clarity on the assessment of computer-related inventions in India, taking into consideration the advancement of emerging technologies such as artificial intelligence, blockchain, etc. The guidelines also address […]

The Plaintiff, F. Hoffmann-La Roche AG filed a suit seeking interim relief against the Defendant, alleging that the Defendants have infringed upon the Plaintiff’s patent for ‘Risdiplam’, an oral drug for Spinal Muscular Atrophy (SMA). The Plaintiff holds an Indian species patent for Risdiplam claiming a specific compound used to treat SMA and they sell […]

In this landmark case, Johnson & Johnson (J&J) sued Pritamdas Arora, trading as M/s Medserve, for large-scale counterfeiting of its registered medical device trademarks, including SURGICEL, ETHICON, and LIGACLIP. In 2019, counterfeit SURGICEL products were discovered in the United States of America and traced it back through a global supply chain to the entity named […]

In June 2024, filmmaker Karan Johar filed a suit before the Bombay High Court seeking to restrain the release and promotion of the film ‘Shaadi Ke Director Karan Aur Johar’. The Plaintiff argued that the film’s title and its use of the names ‘Karan’ and ‘Johar’ as Bollywood directors was a direct and unauthorized reference […]

Recently, the Intellectual Property Division of the Calcutta High Court set aside the rejection of Patent Application No. 4842/KOLNP/2007 titled “Crystalline Modifications to Pyraclostrobin”. The application was filed in 2007, but the Patent Office rejected the patent application in March 2024, with just over a year remaining in the patent’s 20-year term. The Court noted […]